Sitanext 50/500mg 14s
Sitagliptin 50mg and metformin 500mg for type 2 diabetes.
Sitanext 50/500mg 14s combines sitagliptin (DPP-4) 50mg and metformin 500mg for type 2 diabetes when dual therapy is needed. Take once or twice daily with meals as directed; swallow whole.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when combination therapy is appropriate.
Ingredients
Sitagliptin 50mg and metformin hydrochloride 500mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Avoid excessive alcohol. Report severe abdominal pain.
Side Effects
Nausea, diarrhoea, abdominal discomfort, headache. Rare: lactic acidosis (metformin), pancreatitis. Report severe abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Next Pharmaceuticals (PVT.) LTD. |
| Status | Active |
Related Products
